Carboplatin, Gemcitabine, and Pembrolizumab

About

Membership operator: AND

Therapies: 3

Therapies

Carboplatin (tx:ncit:C1282)

Gemcitabine (tx:ncit:C66876)

Pembrolizumab (tx:ncit:C106432)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) ER negative, HER2-negative, PD-L1 (CPS) >= 10, PR negative Invasive Breast Carcinoma Carboplatin, Gemcitabine, Pembrolizumab